Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02159365 · BASELINE

Baseline characteristics

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients · Source last updated 2019-07-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      70
    units
    Participants
groups
  1. description
    E-Ld refers to the combination of Elotuzumab with Lenalidomide/Dexamethasone.
    id
    BG000
    title
    E-Ld
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.40
          value
          67.4
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          49
        title
        < 75 years
      2. measurements
        1. group Id
          BG000
          value
          21
        title
        >= 75 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          35
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          35
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          8
        title
        Hispanic or Latino
      2. measurements
        1. group Id
          BG000
          value
          62
        title
        Not Hispanic or Latino
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Ethnicity (NIH/OMB)
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          57
        title
        White
      2. measurements
        1. group Id
          BG000
          value
          6
        title
        Black or African American
      3. measurements
        1. group Id
          BG000
          value
          3
        title
        Asian
      4. measurements
        1. group Id
          BG000
          value
          0
        title
        American Indian or Alaska Native
      5. measurements
        1. group Id
          BG000
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      6. measurements
        1. group Id
          BG000
          value
          4
        title
        Other
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
        title
        0
      2. measurements
        1. group Id
          BG000
          value
          32
        title
        1
      3. measurements
        1. group Id
          BG000
          value
          4
        title
        2
    description
    ECOG is a 6-item scale used to discern patient status by rating categories such as disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Eastern Cooperative Oncology Group (ECOG) Performance Status
    unit Of Measure
    Participants
population Description
All Treated Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      70
    units
    Participants
groups
  1. description
    E-Ld refers to the combination of Elotuzumab with Lenalidomide/Dexamethasone.
    id
    BG000
    title
    E-Ld
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.40
          value
          67.4
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          49
        title
        < 75 years
      2. measurements
        1. group Id
          BG000
          value
          21
        title
        >= 75 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          35
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          35
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          8
        title
        Hispanic or Latino
      2. measurements
        1. group Id
          BG000
          value
          62
        title
        Not Hispanic or Latino
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Ethnicity (NIH/OMB)
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          57
        title
        White
      2. measurements
        1. group Id
          BG000
          value
          6
        title
        Black or African American
      3. measurements
        1. group Id
          BG000
          value
          3
        title
        Asian
      4. measurements
        1. group Id
          BG000
          value
          0
        title
        American Indian or Alaska Native
      5. measurements
        1. group Id
          BG000
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      6. measurements
        1. group Id
          BG000
          value
          4
        title
        Other
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
        title
        0
      2. measurements
        1. group Id
          BG000
          value
          32
        title
        1
      3. measurements
        1. group Id
          BG000
          value
          4
        title
        2
    description
    ECOG is a 6-item scale used to discern patient status by rating categories such as disease progression, daily functioning, appropriate treatment, and prognosis. Performance status is scored on a scale ranging from 0-5, with (best score) 0=fully active and able to carry on all pre-disease performance without restriction and (worst score) 5=death.
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Eastern Cooperative Oncology Group (ECOG) Performance Status
    unit Of Measure
    Participants
population Description
All Treated Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice